AboutBusiness
HelpPrivacyTerms
RiepilogoLegale e statoCronologiaReteProprietà e organiSociBeneficiario effettivoGeografiaBilancioSalute finanziariaDocumenti
RiepilogoLegale e statoCronologiaReteProprietà e organiSociBeneficiario effettivoGeografiaBilancioSalute finanziariaDocumenti

BIOTELL LIMITED

🇬🇧Regno Unito•Private Limited Company (Ltd.)•Active
Current ratio (2017)Current ratio
19,71×
YoY profit / (loss) (2015 vs 2016)YoY profit / (loss)
+344,2%
Return on assets (net) (2016)Return on assets (net)

Riepilogo

Country🇬🇧Regno Unito
StatusActive
Registration Number08228035
Founded25/09/2012
PurposeWholesale of clothing and footwear
Address63 Victoria Road, Ruislip, HA4 9BH
Confirmation StatementNext due: —; Last made up: —

Dati legali e stato

Legal FormPrivate Limited Company (Ltd.)
StatusActive
Registration Date25/09/2012
Registry AuthorityCompanies House
Registered Capital—

Source: UK Companies House · Last updated: 02/12/2025

Timeline (20 events)

01/11/2025

Address updated

63 Victoria Road, Ruislip, Ha4 9BH

01/04/2025

Address updated

25 Moor Road, Chesham, Hp5 1SD

25/09/2012

Appointed Taghlub Al-kass (person)

Appointed as Director

Rete

Questo grafico ha molte connessioni. per una vista migliore.
Press enter or space to select a node. You can then use the arrow keys to move the node around. Press delete to remove it and escape to cancel.
Press enter or space to select an edge. You can then press delete to remove it or escape to cancel.
Profondità rete

Proprietà e organi

Persons with significant control

Tara Al-kass

25–50% shares

Appointed: 06/04/2016

37.5%
Taghlub Al-kass

25–50% shares

Appointed: 06/04/2016

37.5%
Tara Al-kass

25–50% shares

Appointed: 06/04/2016

37.5%

Officers & directors

Tara Al-kass

Director

Appointed: 18/02/2014

—
Tara Al-kass

Director

Appointed: 25/09/2012

—

Showing 1–5 of 6

1 / 2

Ownership Timeline (2 changes)

06/04/2016

Appointed Tara Al-kass (person)

Person with significant control

06/04/2016

Appointed Taghlub Al-kass (person)

Person with significant control

Soci (azionariato)

NomePartecipazioneVotoDal
▓▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%
▓▓▓▓▓▓▓▓▓▓
██.██%
██.█%
█.██%
▓▓▓▓▓▓▓▓▓▓▓▓
██.█%
█.██%
██%
▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%

Beneficiario effettivo

NomePartecipazionePaeseDal
▓▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%
▓▓▓▓▓▓▓▓▓▓
██.██%
██.█%
█.██%
▓▓▓▓▓▓▓▓▓▓▓▓
██.█%
█.██%
██%
▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%

Geografia

Sede

63 Victoria Road

Ruislip

HA4 9BH

Bilancio e conti

Cifre chiave dai bilanci depositati.

Convert to

2014

Profit / (loss): £0

Key figures

Profit / (loss)

2013—
2014£0
2015£-2382
2016£5817
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—
2025—

Total assets

2013£100
2014£100
2015£-2283
2016£5916
2017£8170
2018£9818
2019£9818
2020£13.408
2021£7655
2022£79.118
2023£19.887
2024£21.728
2025£20.337

Net Assets Liabilities

2013—
2014—
2015—
2016—
2017£8170
2018£9818
2019£9818
2020£13.408
2021£7655
2022£79.118
2023£19.887
2024£21.728
2025£20.337

Equity

2013—
2014—
2015—
2016—
2017£8170
2018£9818
2019£9818
2020£13.408
2021£7655
2022£79.118
2023£19.887
2024£21.728
2025£20.337

Current Assets

2013—
2014£100
2015£99
2016£10.348
2017£11.116
2018£10.110
2019£10.110
2020£14.542
2021£7655
2022£171.341
2023£22.091
2024£24.366
2025£21.839

Net Current Assets Liabilities

2013—
2014£100
2015£99
2016£8298
2017£10.552
2018£9907
2019£9907
2020£13.408
2021£7655
2022£151.449
2023£19.887
2024£21.728
2025£20.337

Total Assets Less Current Liabilities

2013—
2014£100
2015£99
2016£8298
2017£10.552
2018£9907
2019£9907
2020£13.408
2021£7655
2022£151.449
2023£19.887
2024£21.728
2025£20.337

Debtors

2013—
2014—
2015£0
2016£4513
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—
2025—

Creditors

2013—
2014—
2015—
2016—
2017£2382
2018£89
2019£89
2020£1134
2021£0
2022£72.331
2023£2204
2024£2638
2025£1502

Number Shares Allotted

2013100
2014—
2015100
201699
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—
2025—

Par Value Share

2013£1
2014—
2015£1
2016£1
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—
2025—

Average Number Employees During Period

2013—
2014—
2015—
2016—
2017—
2018—
20193
20201
20211
20221
20230
20241
20251

Called Up Share Capital

2013—
2014£100
2015£99
2016£99
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—
2025—

Cash Bank In Hand

2013£100
2014£100
2015£99
2016£711
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—
2025—

Creditors Due After One Year

2013—
2014£0
2015£2382
2016£2382
2017£2382
2018—
2019—
2020—
2021—
2022—
2023—
2024—
2025—

Creditors Due Within One Year

2013—
2014—
2015£0
2016£2050
2017£564
2018—
2019—
2020—
2021—
2022—
2023—
2024—
2025—

Net Assets Liabilities Including Pension Asset Liability

2013£100
2014£100
2015£-2283
2016£5916
2017£8170
2018—
2019—
2020—
2021—
2022—
2023—
2024—
2025—

Profit Loss Account Reserve

2013—
2014£0
2015£-2382
2016£5817
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—
2025—

Share Capital Allotted Called Up Paid

2013£100
2014£100
2015£99
2016£99
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—
2025—

Shareholder Funds

2013£100
2014£100
2015£-2283
2016£5916
2017£8170
2018—
2019—
2020—
2021—
2022—
2023—
2024—
2025—

Stocks Inventory

2013—
2014—
2015£0
2016£5124
2017—
2018—
2019—
2020—
2021—
2022—
2023—
2024—
2025—
Metric2013201420152016201720182019202020212022202320242025
Profit / (loss)—£0£-2382£5817—————————
Total assets£100£100£-2283£5916£8170£9818£9818£13.408£7655£79.118£19.887£21.728£20.337
Net Assets Liabilities————£8170£9818£9818£13.408£7655£79.118£19.887£21.728£20.337
Equity————£8170£9818£9818£13.408£7655£79.118£19.887£21.728£20.337
Current Assets—£100£99£10.348£11.116£10.110£10.110£14.542£7655£171.341£22.091£24.366£21.839
Net Current Assets Liabilities—£100£99£8298£10.552£9907£9907£13.408£7655£151.449£19.887£21.728£20.337
Total Assets Less Current Liabilities—£100£99£8298£10.552£9907£9907£13.408£7655£151.449£19.887£21.728£20.337
Debtors——£0£4513—————————
Creditors————£2382£89£89£1134£0£72.331£2204£2638£1502
Number Shares Allotted100—10099—————————
Par Value Share£1—£1£1—————————
Average Number Employees During Period——————3111011
Called Up Share Capital—£100£99£99—————————
Cash Bank In Hand£100£100£99£711—————————
Creditors Due After One Year—£0£2382£2382£2382————————
Creditors Due Within One Year——£0£2050£564————————
Net Assets Liabilities Including Pension Asset Liability£100£100£-2283£5916£8170————————
Profit Loss Account Reserve—£0£-2382£5817—————————
Share Capital Allotted Called Up Paid£100£100£99£99—————————
Shareholder Funds£100£100£-2283£5916£8170————————
Stocks Inventory——£0£5124—————————

Documenti

Notice of individual person with significant control

19/05/2026

View

Notice of individual person with significant control

19/05/2026

View

Notice of individual person with significant control

19/05/2026

View

Replacement Filing Of Director Appointment With Name

28/04/2026

View

Document AI

Coming soon

Companexia Document AI

Ask questions about filings and extracts—our AI will read the documents and answer in context.

Annual Accounts

Accounts for the accounting period ending on: 28/02/2025

Filed: 28/02/2025

View

Annual Accounts

Accounts for the accounting period ending on: 28/02/2024

Filed: 28/02/2024

View

Annual Accounts

Accounts for the accounting period ending on: 28/02/2023

Filed: 28/02/2023

View

Annual Accounts

Accounts for the accounting period ending on: 28/02/2022

Filed: 28/02/2022

View

Annual Accounts

Accounts for the accounting period ending on: 28/02/2021

Filed: 28/02/2021

View

Showing 1–10 of 18

1 / 2

Altre aziende e persone

🇮🇪KILDALE LIMITED🇮🇪BRAMBURY LIMITED🇮🇪AVONMOUNT LIMITEDMONICA CARVAJAL PHOWARD ZIMMERMANMATHILDE JULIA DESIREE LEGROS
98,3%
Equity ratio (2025)Equity ratio
100%
YoY total assets (2024 vs 2025)YoY total assets
-6,4%

Financial Health

Derived ratios from annual accounts. Values are omitted when data is missing or not meaningful.

Growth

YoY total assets (2014 vs 2015)
-2383%
YoY net current assets (2014 vs 2015)
-1%
YoY profit / (loss) (2015 vs 2016)
+344,2%
YoY total assets (2015 vs 2016)
+359,1%
YoY net current assets (2015 vs 2016)
+8281,8%
  2. –
  3. –
  4. –BIOTELL LIMITED
YoY total assets (2016 vs 2017)
+38,1%
YoY net current assets (2016 vs 2017)
+27,2%
YoY total assets (2017 vs 2018)
+20,2%
YoY net current assets (2017 vs 2018)
-6,1%
YoY total assets (2019 vs 2020)
+36,6%
YoY net current assets (2019 vs 2020)
+35,3%
YoY total assets (2020 vs 2021)
-42,9%
YoY net current assets (2020 vs 2021)
-42,9%
YoY total assets (2021 vs 2022)
+933,5%
YoY net current assets (2021 vs 2022)
+1878,4%
YoY total assets (2022 vs 2023)
-74,9%
YoY net current assets (2022 vs 2023)
-86,9%
YoY total assets (2023 vs 2024)
+9,3%
YoY net current assets (2023 vs 2024)
+9,3%
YoY total assets (2024 vs 2025)
-6,4%
YoY net current assets (2024 vs 2025)
-6,4%
CAGR total assets (2013–2025)
+55,7%

Efficiency & returns

Return on assets (net) (2016)
98,3%

Working capital & liquidity

Net current assets (2014)
100 £
Net current assets (2015)
99 £
Current ratio (2016)
5,05×
Net current assets (2016)
8298 £
Current ratio (2017)
19,71×
Net current assets (2017)
10.552 £
Net current assets (2018)
9907 £
Net current assets (2019)
9907 £
Net current assets (2020)
13.408 £
Net current assets (2021)
7655 £
Net current assets (2022)
151.449 £
Net current assets (2023)
19.887 £
Net current assets (2024)
21.728 £
Net current assets (2025)
20.337 £

Capital structure

Equity ratio (2017)
100%
Equity ratio (2018)
100%
Equity ratio (2019)
100%
Equity ratio (2020)
100%
Equity ratio (2021)
100%
Equity ratio (2022)
100%
Equity ratio (2023)
100%
Equity ratio (2024)
100%
Equity ratio (2025)
100%
Home
Regno Unito
Ruislip